Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer

1. Douillard, J.-Y.
2. Peschel, C.
3. Shepherd, F.
4. Paz-Ares, L.
5. Arnold, A.
6. Davis, M.
7. Tonato, M.
8. Smylie, M.
9. Tu, D.
10. Voi, M.
11. Humphrey, J.
12. Ottaway, J.
13. Young, K.
14. Vreckem, A.V.
15. Seymour, L.